Shangzi Wang

DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma

Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal et al. · Journal for ImmunoTherapy of Cancer · 2021 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells

Sang Soo Kim, Antonina Rait, Farwah Rubab et al. · Molecular Therapy · 2013 · 56 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +17

Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment

Shangzi Wang, Igor Astsaturov, Catherine A. Bingham et al. · Cancer Immunology Immunotherapy · 2011 · 39 citations

Life Sciences, Immunology, Oncology +16

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

Binsheng Gong, Dan Li, Rebecca Kusko et al. · Genome biology · 2021 · 39 citations · Full text

Life Sciences, Molecular Genetics, Oncology +17

Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy

Byoung‐Gie Kim, Shangzi Wang, Ji Min Lee et al. · Oncogene · 2014 · 37 citations

Pharmacy, Cancer Biology, Medicinal Chemistry +16